Press Releases April 27, 2026 08:00 AM

Global-e to Announce Financial Results for the First Quarter 2026 on May 13, 2026

Global-e Online Ltd. to Release Q1 2026 Financial Results on May 13

By Avery Klein
Share
Twitter Reddit Facebook LinkedIn
GLBE

Global-e Online Ltd., a leading platform for global direct-to-consumer e-commerce, announced it will report its financial results for the first quarter ending March 31, 2026, before the market opens on May 13, 2026. The company will host a conference call and webcast to discuss the results and outlook.

Global-e to Announce Financial Results for the First Quarter 2026 on May 13, 2026
GLBE
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Global-e enables over 1,500 brands and retailers worldwide to expand international e-commerce sales.
  • The platform offers localized shopping experiences for consumers in over 200 destinations globally.
  • Financial results announcement is anticipated to provide insights into company performance and global e-commerce trends.

PETAH-TIKVA, Israel, April 27, 2026 (GLOBE NEWSWIRE) -- Global-e Online Ltd. (Nasdaq: GLBE), the platform powering global direct-to-consumer e-commerce, today announced it will report financial results for the first quarter ended March 31, 2026, before market open on Wednesday, May 13, 2026.

Global-e management will host a conference call to review its financial results and outlook.

 Date:Wednesday, May 13, 2026 Time:8:00 AM ET United States/Canada Toll Free:+1-800-717-1738 International Toll:+1-646-307-1865


Please join the call 5-10 minutes prior to the scheduled start time, to avoid a delay in connecting. A live webcast will be available in the Investor Relations section of Global-e’s website at https://investors.global-e.com/news-events/events-presentations

A replay of the webcast will be available in the Investor Relations section of Global-e’s website at https://investors.global-e.com/news-events/events-presentations approximately two hours after the conclusion of the call.

About Global-e Online Ltd.

Global-e (Nasdaq: GLBE) is the world's leading platform enabling and accelerating global, Direct-To-Consumer e-commerce. The chosen partner of over 1,500 brands and retailers across North America, EMEA and APAC, Global-e makes selling internationally as simple as selling domestically. The company enables merchants to increase the conversion of international traffic into sales by offering online shoppers in over 200 destinations worldwide a seamless, localized shopping experience. Global-e's end-to-end e-commerce solutions combine best-in-class localization capabilities, big-data best-practice business intelligence models, streamlined international logistics and vast global e-commerce experience, enabling international shoppers to buy seamlessly online and retailers to sell to, and from, anywhere in the world. For more information, please visit: www.global-e.com.

Investor Contacts:
Alan Katz
Investor Relations
Global-e
[email protected]

Press Contact:
Sarah Schloss
Headline Media
[email protected]
+1 914-506-5104


Risks

  • Uncertainty around the company’s financial performance in the upcoming report may affect investor sentiment.
  • Global economic factors and international trade conditions could impact Global-e's business growth and logistics.
  • Competition in the global e-commerce technology sector could influence future market share and profitability.

More from Press Releases

Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026 Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1 Jun 12, 2026